Monday, November 16th, 2026

India to begin COVID-19 vaccine human trial from next week



NEW DELHI: In a major development, AIIMS Delhi will begin human trials of India’s first indigenous COVID-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55.

The volunteers will be kept under observation for a period of nearly 150 days.

Covaxin is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), IANS reported.

According to Bharat Biotech, The Phase 1 clinical trial for Covaxin has been initiated across the country from July 15 onwards, and this is a randomized, double-blind, placebo-controlled clinical trial on 375 volunteers across the country.

The report added that AIIMS has also set up a dedicated email and phone number for the volunteers to register themselves for this project.

(With inputs from agencies)

Publish Date : 19 July 2020 10:09 AM

Chhath festival concludes with offerings to the rising sun

MAHOTTARI: The Chhath festival concluded on Monday morning with devotees

Tourist influx surges in Bandipur, leaving hotels and homestays fully occupied

DAMAULI: The popular tourist destination of Bandipur in Tanahun has

Water supply resumes in Beni after a month-and-a-half disruption

MYAGDI: Drinking water supply from the Dandakhark source to Beni

Kathmandu Valley’s minimum temperature rises by 2.4 degrees Celsius in a day

KATHMANDU: The minimum temperature in the Kathmandu Valley increased by

Farmers in Ilam busy harvesting paddy as harvest season begins

ILAM: Paddy harvesting has begun in the lower belt of